We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Abbott Diagnostics

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Portable Blood Ammonia Detector Developed

By LabMedica International staff writers
Posted on 04 Aug 2020
Print article
Image: A prototype of the handheld ammonia blood detector and associated test strips (Photo courtesy of Thomas Veltman).
Image: A prototype of the handheld ammonia blood detector and associated test strips (Photo courtesy of Thomas Veltman).
Ammonia is a natural product of digestion that is usually processed into urea by the liver and passed out of the body in urine. Too much ammonia in the blood can cause mental and physical dysfunction and is a concern for people with liver disease or genetic conditions that hinder ammonia metabolism.

Effective treatments exist, but preventing permanent neurological sequelae requires rapid, accurate, and serial measurements of blood ammonia. Standard methods require volumes of 1 to 3 mL, centrifugation to isolate plasma, and a turn-around time of two hours. Collection, handling, and processing requirements mean that community clinics, particularly those in low resource settings, cannot provide reliable measurements.

Biochemists at Stanford University (Stanford, CA, USA) developed a method to measure ammonia from small-volume whole blood samples in two minutes. The method alkalizes blood to release gas-phase ammonia for detection by a fuel cell. The device requires about one drop of blood, less than 1% of the blood for the standard test, and thus can be obtained with a small finger or earlobe prick. The device itself is about the size of a television remote and, as with a glucometer, the blood drops are dabbed onto a test strip that is inserted into one end.

While the sensor inside the device is very similar to existing ammonia sensors (used to detect toxic ammonia gas in industrial settings), the test strips are made from scratch. Blood applied to a small hole at one end of the strip zips through a microscopic channel and sinks into a paper-lined well at the opposite end, which is coated with an inexpensive chemical that liberates the ammonia from the sample. Inside the device, this well sits directly under the ammonia sensor. The device was tested on both adult and pediatric blood samples and showed a strong correlation with an academic clinical laboratory for plasma ammonia concentrations up to 500 μM (16 times higher than the upper limit of normal).

Natalia Gomez-Ospina, MD, PhD, an assistant professor of pediatrics and co-author of the paper, said, “I've spoken with families who have children with metabolic diseases about having this kind of device and it makes them emotional because, for them, the consequences of not getting ammonia checked accurately and quickly are so severe. For these families, it could be life-changing.” The study was published on June 15, 2020 in the journal ACS Sensors.

Related Links:
Stanford University


Print article

Channels

Molecular Diagnostics

view channel
Image: Photomicrograph of histopathology of Barrett`s esophagus showing the characteristic goblet cells (Alcian blue stain) (Photo courtesy of Nephron).

Genomic Copy Number Predicts Esophageal Cancer Years Before Transformation

Barrett’s esophagus is a condition in which the lining of the esophagus changes, becoming more like the lining of the small intestine rather than the esophagus. This occurs in the area where the esophagus... Read more

Immunology

view channel
Image: An enzyme-linked immunosorbent assay for mannose-binding lectin found that this molecule is associated with coagulopathy in severe COVID-19 patients (Photo courtesy of Getty Images).

Mannose-Binding Lectin Associated with Coagulopathy in Severe COVID-19

The ongoing COVID-19 pandemic has caused significant morbidity and mortality worldwide, as well as profound effects on society. COVID-19 patients have an increased risk of thromboembolic (TE) complications,... Read more

Industry News

view channel
Illustration

2020 AACC Annual Scientific Meeting & Clinical Lab Expo to Be an All Virtual Event Due to Coronavirus Pandemic

The American Association for Clinical Chemistry (AACC Washington, DC, USA) has decided to hold the 2020 AACC Annual Scientific Meeting & Clinical Lab Expo as a virtual event, rather than as a live... Read more
Copyright © 2000-2020 Globetech Media. All rights reserved.